Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane.

Maloney SL, Sullivan DC, Suchting S, Herbert JM, Rabai EM, Nagy Z, Barker J, Sundar S, Bicknell R.

Br J Cancer. 2009 Sep 15;101(6):957-66. doi: 10.1038/sj.bjc.6605203.

PMID:
19738618
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.

Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W, Chen XP, Cui L, Wu T, Wang YT.

J Ethnopharmacol. 2012 Jun 1;141(2):721-7. doi: 10.1016/j.jep.2011.08.052. Epub 2011 Sep 3.

PMID:
21911050
[PubMed - indexed for MEDLINE]
3.

PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.

Tian F, Zhang X, Tong Y, Yi Y, Zhang S, Li L, Sun P, Lin L, Ding J.

Cancer Biol Ther. 2005 Aug;4(8):874-82.

PMID:
16082187
[PubMed - indexed for MEDLINE]
Free Article
4.

Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent.

Ren X, Dai M, Lin LP, Li PK, Ding J.

Br J Pharmacol. 2009 Apr;156(8):1228-38. doi: 10.1111/j.1476-5381.2009.00112.x. Epub 2009 Mar 19.

PMID:
19302593
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.

Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.

Cancer Res. 2003 Sep 15;63(18):5978-91. Erratum in: Cancer Res. 2003 Nov 1;63(21):7543.

PMID:
14522925
[PubMed - indexed for MEDLINE]
Free Article
6.

Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.

Shibata A, Nakagawa K, Sookwong P, Tsuzuki T, Oikawa S, Miyazawa T.

Biochem Pharmacol. 2008 Aug 1;76(3):330-9. doi: 10.1016/j.bcp.2008.05.017. Epub 2008 May 28.

PMID:
18599020
[PubMed - indexed for MEDLINE]
7.

Galbanic acid isolated from Ferula assafoetida exerts in vivo anti-tumor activity in association with anti-angiogenesis and anti-proliferation.

Kim KH, Lee HJ, Jeong SJ, Lee HJ, Lee EO, Kim HS, Zhang Y, Ryu SY, Lee MH, Lü J, Kim SH.

Pharm Res. 2011 Mar;28(3):597-609. doi: 10.1007/s11095-010-0311-7. Epub 2010 Nov 10.

PMID:
21063754
[PubMed - indexed for MEDLINE]
8.

Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors.

Olsson A, Björk A, Vallon-Christersson J, Isaacs JT, Leanderson T.

Mol Cancer. 2010 May 17;9:107. doi: 10.1186/1476-4598-9-107.

PMID:
20470445
[PubMed - indexed for MEDLINE]
Free PMC Article
9.
10.

Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells.

Tsai MY, Yang RC, Wu HT, Pang JH, Huang ST.

Cancer Lett. 2011 Nov 28;310(2):198-206. doi: 10.1016/j.canlet.2011.06.031. Epub 2011 Jul 5.

PMID:
21788102
[PubMed - indexed for MEDLINE]
11.

The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions.

Lu L, Payvandi F, Wu L, Zhang LH, Hariri RJ, Man HW, Chen RS, Muller GW, Hughes CC, Stirling DI, Schafer PH, Bartlett JB.

Microvasc Res. 2009 Mar;77(2):78-86. doi: 10.1016/j.mvr.2008.08.003. Epub 2008 Sep 4.

PMID:
18805433
[PubMed - indexed for MEDLINE]
12.

Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4',5-trimethoxylstilbene-3'-O-phosphate disodium (M410).

Cai YC, Zou Y, Ye YL, Sun HY, Su QG, Wang ZX, Zeng ZL, Xian LJ.

Invest New Drugs. 2011 Apr;29(2):300-11. doi: 10.1007/s10637-009-9366-x. Epub 2009 Dec 11.

PMID:
20012336
[PubMed - indexed for MEDLINE]
13.
14.

Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.

Li X, Wang X, Ye H, Peng A, Chen L.

Cancer Chemother Pharmacol. 2012 Sep;70(3):425-37. doi: 10.1007/s00280-012-1923-x. Epub 2012 Jul 20.

PMID:
22814678
[PubMed - indexed for MEDLINE]
15.

CD36-TSP-HRGP interactions in the regulation of angiogenesis.

Silverstein RL, Febbraio M.

Curr Pharm Des. 2007;13(35):3559-67. Review.

PMID:
18220792
[PubMed - indexed for MEDLINE]
16.

Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells.

Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.

Oncol Rep. 2005 Dec;14(6):1399-404.

PMID:
16273231
[PubMed - indexed for MEDLINE]
17.

Anti-angiogenic function of tocotrienol.

Miyazawa T, Shibata A, Nakagawa K, Tsuzuki T.

Asia Pac J Clin Nutr. 2008;17 Suppl 1:253-6.

PMID:
18296349
[PubMed - indexed for MEDLINE]
Free Article
18.

Protein kinase C alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor.

Xu H, Czerwinski P, Hortmann M, Sohn HY, Förstermann U, Li H.

Cardiovasc Res. 2008 May 1;78(2):349-55. Epub 2007 Dec 4.

PMID:
18056764
[PubMed - indexed for MEDLINE]
Free Article
19.

Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis.

Hseu YC, Wu CR, Chang HW, Kumar KJ, Lin MK, Chen CS, Cho HJ, Huang CY, Huang CY, Lee HZ, Hsieh WT, Chung JG, Wang HM, Yang HL.

J Ethnopharmacol. 2011 Jun 1;135(3):762-71. doi: 10.1016/j.jep.2011.04.016. Epub 2011 Apr 14.

PMID:
21515352
[PubMed - indexed for MEDLINE]
20.

Rhizoma Paridis ethanol extract selectively inhibits the proliferation of HUVECs comparing to Lovo cells and shows anti-angiogenesis effects in a mouse model.

Qian X, Zhu L, Hu J, Li M, Xie L, Wang L, Yu L, Liu B.

J Ethnopharmacol. 2012 Aug 30;143(1):256-61. doi: 10.1016/j.jep.2012.06.032. Epub 2012 Jun 28.

PMID:
22750432
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk